Two research teams at Leiden University have secured over €1 million in funding through the NACTAR programme (Dutch Research Agenda) to explore innovative solutions to antimicrobial resistance (AMR).
Led by Prof. Gilles van Wezel, the first project focuses on unlocking hidden antibiotics from soil bacteria using advanced genome-editing tools. The second, led by Dr. Karina Xavier in collaboration with Wageningen University, investigates how gut microbes can be used to prevent infections by outcompeting harmful bacteria.
Both projects reflect the interdisciplinary strength of the Leiden Bio Science Park and aim to contribute to safer, more effective alternatives to traditional antibiotics.
“These projects show how our research ecosystem is driving solutions to critical global challenges,” said an LBSP spokesperson.
Read more on the Leiden University website.
To help address the growing need for well-trained production personnel in the Life Sciences industry, Talentmark and Biotech Training Facility (BTF) are joining forces to...
From 6–9 May 2025, the Netherlands Embassy in Seoul, in collaboration with the Netherlands Enterprise Agency (RVO), is organising a trade mission to South Korea focused on the...
Secure Your Spot in the Dutch Innovator Village at HLTH Europe 2025! Are you ready to present your health tech innovation to the world at HLTH Europe in RAI Amsterdam? Spaces are...